The Reduction or withdrawal of MTX in patients with Rheumatoid Arthritis who achieve low disease activity
Not Applicable
- Conditions
- Rheumatoid Arthritis
- Registration Number
- JPRN-UMIN000028875
- Lead Sponsor
- Asahikawa medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
All participants underwent US examination using both greyscale and power Doppler (PD) technique. We exclude the Patients who have joint soft tissue inflammation over Grade 1 by PDUS method.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the bone and cartilage damage (total sharp Score) after one year
- Secondary Outcome Measures
Name Time Method Disease activity Score(DAS)-CRP, DAS28-ESR, CDAI, SDAI and HAQ